Skip to main content
. 2022 Dec 12;10(12):3225. doi: 10.3390/biomedicines10123225

Figure 4.

Figure 4

(a) Disease-free survival probability for high and low saliva TIMP-1 by the median cut-off of 62.8 ng; (b) comparison of saliva Hsp70 during follow-up (mean per subject) for HNSCC-patients without recurrence, before recurrence, and levels at the time of recurrence; (c) comparison of saliva TIMP-1 during follow-up (mean per subject) for HNSCC-patients without recurrence, before recurrence, and levels at the time of recurrence; and (d) comparison of saliva TIMP-1/Hsp70 ratio during follow-up (mean per subject) for HNSCC patients without recurrence, before recurrence, and levels at the time of recurrence).